Cabaletta Bio (CABA) Interest Coverage Ratio (2024 - 2025)
Cabaletta Bio (CABA) recorded quarterly Interest Coverage Ratio of 76.78 in Q4 2025, up 3.76% quarter-over-quarter from 79.77 in Q3 2025, and down 69.98% on a YoY basis from 255.78 in Q4 2024.
Cabaletta Bio (CABA) Interest Coverage Ratio (2024 - 2025) Analysis & Trends
Cabaletta Bio's Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 76.78 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 69.98% year-over-year to 76.78; the TTM figure through Dec 2025 stood at 85.95 (up 48.63% YoY), while the FY2025 annual figure was 85.95, up 48.63% from the prior year.
- Interest Coverage Ratio was 76.78 for Q4 2025 at Cabaletta Bio, up from 79.77 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 45.17 in Q4 2024 to a low of 126.31 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | -76.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -76.78 |
| Sep 30, 2025 | -79.77 |
| Jun 30, 2025 | -80.40 |
| Mar 31, 2025 | -126.31 |
| Dec 31, 2024 | -45.17 |